Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,537.10
(
-1.05%
)
US TECH 100
23,404.00
(
-1.34%
)
Dow Jones
45,772.44
(
-0.54%
)
Brent Oil
107.37
(
2.81%
)
Bitcoin
69,567.00
(
-0.47%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

oldberkeley

Send PM Follow Ignore
Followers 58
Posts 5142
Boards Moderated 0
Alias Born 07/23/2007

oldberkeley

Re: DewDiligence post# 127003

Wednesday, 09/21/2011 2:12:36 PM

Wednesday, September 21, 2011 2:12:36 PM

Post# of 257262
I read it at the time and just reviewed it.

I'm not a scientist, but the substance of their suit seems to be just what I'm suggesting: it's impossible for TEVA (insert Amphastar if applicable) or any company to manufacture enoxaparin without violating certain of MNTA's patents during the process.

Am I missing something here? TIA
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today